• Microglial Nr4a1 and Neuronal C3 in TMJ Inflammation–Linked

  2026-05-22

  This study identifies a mechanism linking temporomandibular joint (TMJ) inflammation to depression-like behaviors via microglial Nr4a1 deficiency and neuronal complement C3–mediated synaptic pruning in the hippocampus. The findings provide mechanistic targets for future interventions in TMD-associated emotional complications.

• Optimizing Cell Signaling Assays with Melittin (SKU B6628)

  2026-05-22

  This article explores practical laboratory challenges in cell viability and signaling studies, demonstrating how Melittin (SKU B6628) from APExBIO serves as a reproducible, data-driven solution for apoptosis and cancer biology research. Scenario-driven Q&As guide users in protocol optimization, data interpretation, and vendor selection, with an emphasis on evidence-based best practices and workflow reliability.

• Machine Learning Accelerates LNP Design for mRNA Vaccine Del

  2026-05-21

  This study introduces a machine learning framework to predict and optimize lipid nanoparticle (LNP) formulations for mRNA vaccine delivery. By systematically analyzing ionizable lipid structures and validating predictions experimentally, the research offers a scalable pathway to streamline mRNA vaccine development.

• Nocodazole: Microtubule Polymerization Inhibitor in Action

  2026-05-21

  Nocodazole from APExBIO empowers researchers with precise, reversible control over microtubule assembly, streamlining experimental workflows in cell cycle regulation and cancer research. Explore optimized protocols, novel mechanistic insights, and troubleshooting strategies for reproducible results in advanced cytoskeleton studies.

• Protoporphyrin IX: From Heme Biosynthesis to Photodynamic Th

  2026-05-20

  Explore the multifaceted role of Protoporphyrin IX, a pivotal photodynamic compound in heme formation and innovative cancer diagnostics. This article uniquely bridges molecular mechanisms and protocol insights for translational applications.

• SM-164: Bivalent Smac Mimetic Empowering Apoptosis Research

  2026-05-20

  SM-164 redefines apoptosis research by enabling precise, rapid IAP antagonism and robust TNFα-dependent cell death in tumor models. Its performance, solubility, and compatibility with advanced caspase and cell death assays make it an indispensable tool for dissecting regulated apoptosis—especially in the era of RNA Pol II-targeted therapies.

• Epigenetic and Vesicle Responses in Shrimp Immunity Post-Vib

  2026-05-19

  This study offers the first temporal analysis of histone modifications and small extracellular vesicles in shrimp hemocytes after inactivated Vibrio parahaemolyticus priming. The findings reveal dose-specific, transient chromatin changes and extracellular vesicle dynamics, establishing a baseline for future research on invertebrate immune memory and intercellular communication.

• Angiotensin Peptides Enhance SARS-CoV-2 Spike–AXL Binding

  2026-05-19

  This study reveals that naturally occurring angiotensin peptides, including Angiotensin 1/2 (1-6), can significantly enhance the binding of the SARS-CoV-2 spike protein to the AXL receptor. These findings suggest a mechanistic bridge between the renin-angiotensin system and viral pathogenesis, with implications for both cardiovascular and COVID-19 research.

• PP2A-Modulated Autophagy Drives Drug Resistance in C. albica

  2026-05-18

  This study reveals that protein phosphatase 2A (PP2A) regulates autophagy via ATG protein phosphorylation in Candida albicans, promoting biofilm formation and antifungal drug resistance. Targeting PP2A-mediated autophagy, such as with mTOR inhibitors like Rapamycin, may offer new strategies for overcoming biofilm-associated resistance.

• GDC-0941: Strategic Insights for Translational PI3K Inhibiti

  2026-05-18

  This thought-leadership article unpacks the mechanistic rationale and translational impact of GDC-0941, a potent and selective PI3K inhibitor targeting class I isoforms. Blending primary literature, workflow guidance, and clinical context, we explore how GDC-0941—available from APExBIO—serves as a pivotal tool for dissecting PI3K/Akt pathway inhibition, overcoming resistance in cancer models, and guiding next-generation therapeutic strategies. The analysis is anchored in contemporary findings on pathway crosstalk, resistance mechanisms, and the evolving landscape of oncology research.

• Tetracycline in Advanced Ribosomal and ER Stress Assays

  2026-05-17

  Tetracycline, a broad-spectrum polyketide antibiotic from APExBIO, powers precise antibiotic selection and ribosomal function studies. Explore how its unique mechanistic features and robust purity drive innovation in ER stress modeling, with evidence-based guidance for optimizing workflows and troubleshooting persistent experimental challenges.

• Machine Learning Reveals Senescence-Inducing Compounds in Gl

  2026-05-16

  This study pioneers a machine learning approach for identifying senescence in glioblastoma cells using DAPI imaging, enabling high-throughput discovery of senescence-inducing compounds. The findings advance both phenotypic screening and mechanistic research into senescence as a therapeutic strategy in aggressive brain cancer.

• WTAP Overexpression Drives Poor Prognosis in AML via m6A-MYC

  2026-05-15

  This study uncovers that Wilms’ tumor 1-associated protein (WTAP) is highly expressed in acute myeloid leukemia (AML) and predicts poor prognosis by regulating m6A methylation of MYC mRNA. The findings clarify WTAP’s epigenetic role in AML progression and resistance, providing a mechanistic basis for targeted research into mRNA modification and leukemia therapy.

• Microglial Nr4a1–C3 Axis Links TMJ Inflammation to Depressio

  2026-05-15

  This study unveils how microglial Nr4a1 deficiency and neuronal C3 upregulation mediate hippocampal synaptic pruning and depression-like behaviors following TMJ inflammation. The findings illuminate a mechanistic neuroimmune pathway underlying emotional complications in TMD and suggest new molecular targets for intervention.

• RNASEH1-AS1 as a Prognostic lncRNA Biomarker in Hepatocellul

  2026-05-14

  This study identifies the long non-coding RNA RNASEH1-AS1 as an independent prognostic and diagnostic biomarker in hepatocellular carcinoma (HCC), revealing its oncogenic roles and molecular interactions. The work integrates bioinformatic and experimental approaches, providing new insights into HCC progression and actionable targets for future research.

16022 records 1/1069 page Next 12345 下5页 Last page